Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
Sales | 85 | 53 | 0 | 547 | 0 |
Gross Profit | 85 | 53 | N/A | 547 | N/A |
Operating Expenses | 1,269 | 1,326 | 1,127 | 1,894 | 10,244 |
Operating Income | -1,184 | -1,273 | -1,127 | -1,347 | -10,244 |
Pre-tax Income | -1,184 | -1,273 | -1,127 | -1,347 | -10,244 |
Net Income Continuous | -1,184 | -1,273 | -1,127 | -1,347 | -10,244 |
Net Income | $-1,184 | $-1,273 | $-1,127 | $-1,347 | $-10,244 |
EPS Basic Total Ops | -0.13 | -0.16 | -0.17 | 0.52 | -2.64 |
EPS Basic Continuous Ops | -0.13 | -0.16 | -0.17 | 0.49 | -2.64 |
EPS Diluted Total Ops | -0.13 | -0.16 | -0.17 | 0.52 | -2.64 |
EPS Diluted Continuous Ops | -0.13 | -0.16 | -0.17 | 0.49 | -2.64 |
EBITDA(a) | $-1,161 | $-1,254 | $-1,109 | $-1,326 | $-10,227 |